|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$54,718.92 |
2.75% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$54,405.94 |
2.73% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$52,686.81 |
2.65% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$51,798.52 |
2.60% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$49,509.89 |
2.49% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$49,472.10 |
2.48% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$48,065.90 |
2.41% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$47,285.83 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,603.47 |
2.34% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$44,665.20 |
2.24% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$44,594.24 |
2.24% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$44,441.32 |
2.23% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$44,432.03 |
2.23% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$43,978.91 |
2.21% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$43,779.73 |
2.20% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$42,764.53 |
2.15% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$42,192.15 |
2.12% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$41,894.30 |
2.10% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$41,616.15 |
2.09% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$41,155.20 |
2.07% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$40,890.40 |
2.05% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$40,436.39 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$40,132.30 |
2.02% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$40,079.34 |
2.01% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$40,080.72 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$39,662.70 |
1.99% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$38,739.85 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$38,866.80 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,869.37 |
1.90% |
| Steris Plc |
STE |
G8473T100 |
177 |
$37,750.56 |
1.90% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$37,878.72 |
1.90% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$37,656.21 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$37,564.80 |
1.89% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$37,668.68 |
1.89% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$37,486.96 |
1.88% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$37,460.06 |
1.88% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$36,465.18 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$35,602.99 |
1.79% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$35,575.96 |
1.79% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,658.79 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$35,438.33 |
1.78% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$35,017.50 |
1.76% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,883.92 |
1.75% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,382.26 |
1.73% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$31,954.00 |
1.60% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,618.34 |
1.54% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,602.20 |
1.49% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$28,729.58 |
1.44% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,410.20 |
1.43% |
| US Dollar |
$USD |
|
8,916 |
$8,916.45 |
0.45% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| New Zealand Dollar |
$NZD |
|
-104 |
($59.24) |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|